Ken Griffin
CPIX icon

Ken Griffin’s Cumberland Pharmaceuticals CPIX Stock Holding History

Ken Griffin’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67K Buy
20,600
+6,700
+48% +$25.8K ﹤0.01% 12276
2025
Q4 		$55.3K Buy
13,900
+2,400
+21% +$7.11K ﹤0.01% 11991
2025
Q3 		$35.9K Buy
+11,500
New +$38.2K ﹤0.01% 12334
2025
Q2 		– Sell
-35,000
Closed -$148K – 12858
2025
Q1 		$148K Sell
35,000
-1,400
-4% -$5.8K ﹤0.01% 10897
2024
Q4 		$86.3K Sell
36,400
-7,800
-18% -$11.5K ﹤0.01% 11683
2024
Q3 		$56.6K Buy
44,200
+20,000
+83% +$27.7K ﹤0.01% 11774
2024
Q2 		$37K Sell
24,200
-13,900
-36% -$21.9K ﹤0.01% 12065
2024
Q1 		$64K Sell
38,100
-2,500
-6% -$4.99K ﹤0.01% 11928
2023
Q4 		$70.6K Buy
40,600
+8,200
+25% +$15K ﹤0.01% 11380
2023
Q3 		$61.2K Buy
32,400
+100
+0.3% +$168 ﹤0.01% 11503
2023
Q2 		$47.5K Buy
32,300
+8,800
+37% +$15.2K ﹤0.01% 11858
2023
Q1 		$45.8K Buy
23,500
+21,500
+1,075% +$51.1K ﹤0.01% 12272
2022
Q4 		$4.5K Buy
+2,000
New +$4.64K ﹤0.01% 14092
2022
Q3 		– Sell
-32,300
Closed -$67K – 12740
2022
Q2 		$67K Buy
32,300
+18,100
+127% +$41.9K ﹤0.01% 11734
2022
Q1 		$40K Buy
+14,200
New +$47.2K ﹤0.01% 12929

Other funds holding CPIX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ken Griffin's CPIX Position: Q1 2026 in Review

Ken Griffin reduced its Cumberland Pharmaceuticals (CPIX) stake by 24% in Q1 2026, selling an estimated $20.5K and leaving 16,643 shares worth $54.1K. The position accounts for ﹤0.01% of the portfolio, ranked #12375.

Ken Griffin first reported a position in CPIX in Q2 2013 and has held it in 18 quarters since. The position peaked at $249K in Q2 2025. 29 funds tracked by Wall St. Rank hold CPIX as of Q1 2026.

  • Ken Griffin held 16,643 shares of Cumberland Pharmaceuticals worth $54.1K as of Q1 2026.
  • Ken Griffin sold 5,314 Cumberland Pharmaceuticals shares in Q1 2026, an estimated $20.5K.
  • Cumberland Pharmaceuticals made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #12375 holding.
  • Ken Griffin first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 18 quarters since.
  • Ken Griffin's Cumberland Pharmaceuticals position peaked at $249K in Q2 2025.
  • 29 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.